title: Effect of anti-allergic agents on chemotaxis of neutrophils by stimulation of chemotactic factor released from hepatocytes exposed to ethanol.
abstract: In an attempt to clarify a mechanism of neutrophil infiltration in the liver of alcoholics and possible therapeutic effect of antiallergic agents on accumulation of these cells in the liver, we investigated chemotaxis of neutrophils by stimulation of a chemotactic factor released from rat hepatocytes exposed to ethanol. When hepatocytes were incubated with more than 30 mM ethanol for 24 hr, chemotactic activity for both rat and human neutrophils was demonstrated in the conditioned medium. An enhanced chemotactic activity of the conditioned medium was reduced in the presence of antibody against KC/gro protein, one of the interleukin-8-related cytokines in rodents. Antiallergic agents such as azelastine or ketotifen at a concentration of > 0.01 microM markedly reduced chemotaxis of neutrophils. Prednisolone at a concentration of > 10 microM also reduced chemotaxis of neutrophils. These results suggest that neutrophil accumulation in the liver of human alcoholics could be induced by a chemotactic factor produced by the ethanol-treated hepatocytes and that antiallergic agents could be effective against the extent of alcoholic hepatitis by reducing chemotaxis of neutrophils.
authors.affiliation: Department of Gastroenterology and Hepatology, Koshigaya Hospital, Dokkyo University School of Medicine, Saitama, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Shiratori
authors.forename: H
authors.initials: H
authors.lastname: Takada
authors.forename: K
authors.initials: K
authors.lastname: Hai
authors.forename: H
authors.initials: H
authors.lastname: Kiriyama
authors.forename: E
authors.initials: E
authors.lastname: Mawet
authors.forename: Y
authors.initials: Y
authors.lastname: Komatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Niwa
authors.forename: M
authors.initials: M
authors.lastname: Matsumura
authors.forename: S
authors.initials: S
authors.lastname: Shiina
authors.forename: T
authors.initials: T
authors.lastname: Kawase
mesh_terms: D000328:Adult; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002478:Cells, Cultured; D018925:Chemokines; D002630:Chemotactic Factors / Q000378:metabolism*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D017077:Culture Media, Conditioned; D016207:Cytokines / Q000276:immunology; D000431:Ethanol / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007665:Ketotifen / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology; D010793:Phthalazines / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000906:Antibodies; D018925:Chemokines; D002630:Chemotactic Factors; D017077:Culture Media, Conditioned; D016207:Cytokines; D006634:Histamine H1 Antagonists; D010793:Phthalazines; C074302:keratinocyte-derived chemokines; D000431:Ethanol; D011239:Prednisolone; D007665:Ketotifen; C020976:azelastine